Troels Korshøj Bergmann

Troels Korshøj Bergmann is a Clinical Professor at the Department of Regional Health Research, IRS - Esbjerg and Grindsted Hospital, affiliated with the University of Southern Denmark, Faculty of Health Sciences. He is actively engaged in clinical pharmacology research and patient care, with a focus on drug safety, pharmacokinetics, and personalized medicine.

His research interests lie at the intersection of pharmacology and clinical practice, particularly in pharmacokinetics, pharmacogenetics, and therapeutic drug monitoring. His work investigates the behavior of drugs such as tacrolimus, mycophenolic acid, paclitaxel, and repaglinide, with emphasis on optimizing dosing in kidney transplant recipients and cancer patients. He explores drug-drug interactions involving CYP450 enzymes, especially CYP2C8, to improve prescribing safety.

The recent publications highlight a strong trend in individualized pharmacotherapy, population pharmacokinetic modeling, and clinical implementation of drug monitoring strategies. His contributions span both empirical research and educational initiatives, including the adaptation of prescribing safety assessments for Danish medical graduates.

Prof. Bergmann is actively involved in professional service, including editorial work for Basic & Clinical Pharmacology & Toxicology and leadership roles in the Danish Society for Clinical Pharmacology. He has served on national committees related to hospital medicine and drug use.

He supervises research and contributes to academic training, though specific student names are not listed. His work is supported by institutional affiliations and collaborative networks across Scandinavia and Europe. He is also involved with the Research Unit of Emergency Medicine in Esbjerg, indicating a multidisciplinary clinical engagement.